Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426)
02/2011
02/17/2011US20110039810 Use of 25-hydroxy-vitamin d3 to affect human muscle physiology
02/16/2011EP1735276B1 Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues
02/15/2011US7888339 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
02/15/2011US7888338 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes
02/01/2011US7879829 19-nor-vitamin D analogs with 1,2-dihydrofuran ring
01/2011
01/26/2011EP2004597B1 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain
01/12/2011EP1814847B1 Novel method for preparing 3-[5'-(3,4-bis-hydroxymethyl-benzyloxy)-2'- ethyl-2-propyl-biphenyl-4-yl]-penta-3-ol
01/06/2011WO2011002756A2 Vitamin d compounds and methods for preparing same
01/04/2011CA2477543C Method of synthesizing 1.alpha.-hydroxy-2-methylene-19-nor-homopregnacalciferol
12/2010
12/29/2010CN1948283B Preparation method of vitamin D derivative
12/22/2010EP2262765A1 Stabilized 1,25-dihydroxyvitamin d2 and method of making same
12/15/2010EP1556345B1 Vitamin d analogues, compositions comprising said analogues and their use
12/15/2010CN101918358A New vitamin D receptor activators and methods of making
12/08/2010CN101318988B Sterol extracted from crude glycerine and extracting method thereof
12/07/2010CA2488334C 24-sulfoximine vitamin d3 compounds
12/01/2010CN101265225B Method for oxidizing unsaturated conjugated enol
11/2010
11/18/2010WO2010111241A3 Methods and devices for in situ determination of a vitamin-d synthesizing amount of natural and artificial uv irradiation
11/10/2010EP2247563A1 13,13-dimethyl-des-c,d analogs of 1alpha, 25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
11/10/2010CN101880253A Preparation method of paricalcitol
10/2010
10/28/2010US20100273748 Antimicrobial therapy
10/27/2010CN101870708A Method for preparing vitamin D2 derivative
10/21/2010WO2010120698A1 Vitamin d receptor agonists and uses thereof
10/21/2010CA2758698A1 Vitamin d receptor agonists and uses thereof
10/20/2010EP2240440A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs
10/20/2010EP2240439A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
10/20/2010EP2240438A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs
10/20/2010CN101863809A Method for purifying doxercalciferol
10/13/2010EP2237837A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
09/2010
09/29/2010CN101845073A Preparation method and application of 1alpha-dehydroepiandrosterone
09/28/2010US7803789 Vitamin D analog—RAK, methods and uses thereof
09/21/2010CA2458415C 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3
09/15/2010CN101830840A Method for producing vitamin D3
09/15/2010CN101830839A Method for synthesizing Seocalcitol
09/14/2010US7795459 Paricalcitol purification
09/08/2010CN101001835B Epimerisation of allylic alcohols
09/02/2010WO2009094426A8 13,13-dimethyl-des-c,d analogs of 1alpha, 25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
09/01/2010EP2222635A2 New vitamin d receptor activators and methods of making
08/2010
08/26/2010WO2010095425A1 Method for producing crystals of vitamin d derivative
08/25/2010CN101096354B Method for oriented synthesis of unsaturated conjugated alcohol
08/19/2010US20100209536 Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases
07/2010
07/27/2010US7763599 Retinoic esters with cholesterol; antiproliferative agents; disorders caused by abnormal cellular differentiation; psoriasis, cancers of skin, colon, lungs, breasts, prostate, or ovaries, leukemia, neuroblastomas, eczema, acne; improved wrinkle resistance, skin hydration, sebum secretions
07/27/2010US7763598 1 alpha -hydroxy-2-[3'-hydroxypropylidene]-20-methyl-19, 24, 25, 26, 27-pentanorvitamin D3, used as an anticarcinogenic agent, for the treatment of skin disorders, autoimmune diseases, inflammatory diseases, renal osteodystrophy, and/or prevention of obesity
07/27/2010CA2168728C Vitamin d3 derivative and production process thereof
07/15/2010US20100179344 2-Alkylidene-18,19-Dinor-Vitamin D Compounds
07/06/2010CA2446149C Vitamin d analogues
06/2010
06/10/2010US20100145105 Novel phenylboronic acid compounds and intermediates and processes for the preparation thereof
06/10/2010US20100144683 Methods for generating mammalian models of atopic diseases, and screening for their treatment
06/03/2010WO2010060197A1 Method for synthesizing vitamin d analogs
06/03/2010US20100137262 Low Calcemic, Highly Antiproliferative, Analogs of Calcitriol
06/03/2010CA2744591A1 Method for synthesizing vitamin d analogs
06/02/2010CN1938268B Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues
06/01/2010CA2572607C Epimerisation of allylic alcohols
05/2010
05/27/2010US20100130454 9,10-secopregnane derivatives and medicine
05/26/2010CN101068779B 9,10-secopregnane derivative and medicine
05/20/2010WO2010006162A3 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs
05/19/2010CN101711233A Low calcemic, highly antiproliferative, analogs of calcitriol
05/19/2010CN101130511B Polyhydroxy opened loop sterol, method for preparing the same and antineoplastic use of the same
05/18/2010US7718638 Arresting the proliferation of undifferentiated cells and inducing their differentiation; anticancer agents; treating psoriasis, wrinkles, slack skin, dry skin, insufficient sebum secretion, autoimmune disorders, inflammatory diseases, renal osteodystrophy. and obesity; little, if any, calcemic activity
05/18/2010US7718637 Arresting the proliferation of undifferentiated cells and inducing their differentiation; anticancer agents; treating psoriasis, wrinkles, slack skin, dry skin, insufficient sebum secretion, autoimmune disorders, inflammatory diseases, renal osteodystrophy. and obesity; little, if any, calcemic activity
05/18/2010US7718636 Administering to a post menopausal woman an effective amount of 2-methylene -19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3
05/12/2010EP1828113B1 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
05/11/2010US7713953 2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
05/11/2010US7713952 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses
05/11/2010US7713951 2-alkylidene-18,19-dinor-vitamin D compounds
05/06/2010US20100113378 Compositions and Methods for Treating and Preventing Cancer Using Analogs of Vitamin D
04/2010
04/29/2010WO2010006129A3 2-methylene-(22e)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs
04/28/2010EP2178833A2 Process for the preparation of calcipotriol
04/27/2010US7704982 2-methylene-19-nor-1α-hydroxy-17-ene-homopregnacalciferol and its uses
04/27/2010US7704981 To decrease the calcemic effect while retaining the ability to suppress parathyroidhormone; hormone inhibitors; metabolic bone disorders; psoriasis; anticarcinogenic agents; transplant rejection; skin disorders; renal osteodystrophy; osteoporosis; vitamin D-resistant rickets; antiarthritic agents;
04/27/2010US7704980 ulcerative colitis and Crohn's disease; 1 alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol or 2-methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3
04/22/2010WO2010009879A3 Methods for producing paricalcitol
04/21/2010CN101695648A Negative pressure continuous ultraviolet photochemical reactor
04/20/2010US7700657 Vitamin D analogs
04/15/2010WO2010006169A3 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs
04/15/2010WO2010006135A3 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs
04/08/2010WO2010006172A3 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs
04/08/2010US20100087669 Novel phenylboronic acid compounds and intermediates and processes for the preparation thereof
04/08/2010US20100087404 Method of treating and preventing hyperparathyroidism with active vitamin d analogs
04/01/2010WO2010006125A3 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs
03/2010
03/23/2010CA2393617C Vitamin d precursors, method and intermediates
03/18/2010US20100069339 Novel method of treatment of male sub-fertility
03/17/2010CN101671288A Preparation method of intermediate of paricalcitol
03/11/2010US20100063307 Paricalcitol purification
03/11/2010CA2673905A1 Paricalcitol purification
03/11/2010CA2639477A1 Paricalcitol purification
03/10/2010CN101668739A Photochemical process for the preparation of a previtamin d
03/03/2010CN101663269A Photochemical process for the preparation of a previtamin d
02/2010
02/18/2010US20100041631 Methods and agents for treating tuberculosis
02/11/2010US20100036140 Sterols modified by polyethylene glycol, the preparation and the use thereof
02/09/2010US7659421 4-(1-Ethyl-1-hydroxypropyl)-2-propylphenylboronic acid; intermediate for non-steroidal Vitamin D3 derivatives using Suzuki-type coupling ; bromination of methyl 4-bromo-3-methylbenzoate, alkylation; deesterification; hydroxylation; reacting with a trialkyl borate
02/09/2010CA2403756C Structural modification of 19-norprogesterone i: 17-.alpha.-substituted, 11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
01/2010
01/28/2010WO2010011906A1 Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
01/28/2010WO2010009879A2 Methods for producing paricalcitol
01/28/2010CA2731382A1 Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
01/21/2010US20100016263 9, 10-secopregnane derivative and pharmaceutical
01/20/2010EP2144872A2 Low calcemic, highly antiproliferative, analogs of calcitriol
01/19/2010US7648974 19-nor-vitamin D analogs with 3,2-dihydrofuran ring
01/19/2010US7648973 Metabolic bone disease; psoriasis; leukemia; colon, breast, prostate, skin, lung cancer; multiple sclerosis; lupus; diabetes mellitus; host versus graft reaction; rejection of organ transplants; an inflammatory disease selected from rheumatoid arthritis, asthma, psoriasis
01/19/2010US7648972 2-methylene-1α-hydroxy-19,21-dinorvitamin D3 analogs and uses thereof
01/19/2010CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 35